Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Oncomed Pharmaceuticals Inc (OMED)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2018 Q2 | 219,420 | <0.01 | $2.31 | $507,000 | SEC | ||
| 2018 Q1 | 219,420 | <0.01 | $3.18 | $698,000 | SEC | ||
| 2017 Q4 | 219,420 | <0.01 | $4.10 | $900,000 | SEC | ||
| 2017 Q3 | 219,420 | <0.01 | $4.52 | $992,000 | SEC | ||
| 2017 Q2 | 219,420 | <0.01 | Add 37.64% | <0.01 | $3.33 | $731,000 | SEC |
| 2017 Q1 | 159,420 | <0.01 | Reduce 30.81% | <0.01 | $9.21 | $1,468,000 | SEC |
| 2016 Q4 | 230,400 | <0.01 | $7.71 | $1,776,000 | SEC | ||
| 2016 Q3 | 230,400 | 0.01 | Add 197.79% | <0.01 | $11.43 | $2,633,000 | SEC |
| 2016 Q2 | 77,370 | <0.01 | Reduce 58.05% | <0.01 | $12.30 | $952,000 | SEC |
| 2016 Q1 | 184,430 | <0.01 | Buy | <0.01 | $10.11 | $1,865,000 | SEC |